作者: H. Joensuu
DOI: 10.1007/978-3-642-84892-6_14
关键词:
摘要: Hodgkin’s disease can be effectively treated with irradiation, and the role of radiation therapy is well established in management early-stage disease. About 80% patients stage I or II who are free from constitutional symptoms will live relapse for 10 years diagnosis if irradiation alone (Hoppe et al. 1982; Mauch 1988). As cure rate has increased, late complications have become increasingly important.